Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Winters

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
The Journal of Infectious Diseases|July 1, 1995
Drug resistance and heterogeneous long-term virologic responses of human immunodeficiency virus type 1-infected subjects to zidovudine and didanosine combination therapy. The AIDS Clinical Trials Group 143 Virology TeamR W Shafer, A K Iversen, M A Winters, et al.
AIDS (London, England)|February 1, 1996
The prognostic significance of serum viral load, codon 215 reverse transcriptase mutation and CD4+ T cells on progression of HIV disease in a double-blind study of thymopentinT C Merigan, R L Hirsch, A C Fisher, et al.
Annals of Internal Medicine|June 15, 1996
The effect of high-dose saquinavir on viral load and CD4+ T-cell counts in HIV-infected patientsJ M Schapiro, M A Winters, F Stewart, et al.
Journal of Acquired Immune Deficiency Syndromes|August 1, 1994
HIV-1 syncytium-inducing phenotype, virus burden, codon 215 reverse transcriptase mutation and CD4 cell decline in zidovudine-treated patientsM J Kozal, R W Shafer, M A Winters, et al.
Annals of Internal Medicine|August 15, 1994
Didanosine resistance in HIV-infected patients switched from zidovudine to didanosine monotherapyM J Kozal, K Kroodsma, M A Winters, et al.
Journal of Virology|October 24, 2000
Genotypic, phenotypic, and modeling studies of a deletion in the beta3-beta4 region of the human immunodeficiency virus type 1 reverse transcriptase gene that is associated with resistance to nucleoside reverse transcriptase inhibitorsM A Winters, K L Coolley, P Cheng, et al.
Journal of Virology|February 1, 1996
Multidrug-resistant human immunodeficiency virus type 1 strains resulting from combination antiretroviral therapyA K Iversen, R W Shafer, K Wehrly, et al.
Journal of Pharmaceutical Sciences|June 1, 1996
Precipitation of proteins in supercritical carbon dioxideM A Winters, B L Knutson, P G Debenedetti, et al.
The Journal of Infectious Diseases|December 8, 1998
Resistance mutations to zidovudine and saquinavir in patients receiving zidovudine plus saquinavir or zidovudine and zalcitabine plus saquinavir in AIDS clinical trials group 229J M Schapiro, J Lawrence, R Speck, et al.
Antiviral Therapy|June 10, 2000
Frequency of antiretroviral drug resistance mutations in HIV-1 strains from patients failing triple drug regimens. The Terry Beirn Community Programs for Clinical Research on AIDSM A Winters, J D Baxter, D L Mayers, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
The Journal of Infectious Diseases|July 1, 1995
Drug resistance and heterogeneous long-term virologic responses of human immunodeficiency virus type 1-infected subjects to zidovudine and didanosine combination therapy. The AIDS Clinical Trials Group 143 Virology TeamR W Shafer, A K Iversen, M A Winters, et al.
AIDS (London, England)|February 1, 1996
The prognostic significance of serum viral load, codon 215 reverse transcriptase mutation and CD4+ T cells on progression of HIV disease in a double-blind study of thymopentinT C Merigan, R L Hirsch, A C Fisher, et al.
Annals of Internal Medicine|June 15, 1996
The effect of high-dose saquinavir on viral load and CD4+ T-cell counts in HIV-infected patientsJ M Schapiro, M A Winters, F Stewart, et al.
Journal of Acquired Immune Deficiency Syndromes|August 1, 1994
HIV-1 syncytium-inducing phenotype, virus burden, codon 215 reverse transcriptase mutation and CD4 cell decline in zidovudine-treated patientsM J Kozal, R W Shafer, M A Winters, et al.
Annals of Internal Medicine|August 15, 1994
Didanosine resistance in HIV-infected patients switched from zidovudine to didanosine monotherapyM J Kozal, K Kroodsma, M A Winters, et al.
Journal of Virology|October 24, 2000
Genotypic, phenotypic, and modeling studies of a deletion in the beta3-beta4 region of the human immunodeficiency virus type 1 reverse transcriptase gene that is associated with resistance to nucleoside reverse transcriptase inhibitorsM A Winters, K L Coolley, P Cheng, et al.
Journal of Virology|February 1, 1996
Multidrug-resistant human immunodeficiency virus type 1 strains resulting from combination antiretroviral therapyA K Iversen, R W Shafer, K Wehrly, et al.
Journal of Pharmaceutical Sciences|June 1, 1996
Precipitation of proteins in supercritical carbon dioxideM A Winters, B L Knutson, P G Debenedetti, et al.
The Journal of Infectious Diseases|December 8, 1998
Resistance mutations to zidovudine and saquinavir in patients receiving zidovudine plus saquinavir or zidovudine and zalcitabine plus saquinavir in AIDS clinical trials group 229J M Schapiro, J Lawrence, R Speck, et al.
Antiviral Therapy|June 10, 2000
Frequency of antiretroviral drug resistance mutations in HIV-1 strains from patients failing triple drug regimens. The Terry Beirn Community Programs for Clinical Research on AIDSM A Winters, J D Baxter, D L Mayers, et al.
Pageof 5